ArticleActa obstetricia et gynecologica Scandinavica2025
Long-term cardiovascular risk in women with hypertensive disorders of pregnancy: Insights from polygenic risk scores.
Article in Acta obstetricia et gynecologica Scandinavica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Long-term cardiovascular risk in women with hypertensive disorders of pregnancy: Insights from polygenic risk scores.Acta obstetricia et gynecologica Scandinavica · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionThe association between preeclampsia (PE) and an elevated risk of cardiovascular disease (CVD) is well documented. Recent genome-wide association studies of PE have further highlighted their possible common genetic background. We investigated how the history of hypertensive disorders of pregnancy (HDP), including the PE phenotype, and normotensive pregnancy, combined with polygenic risk scores (PRSs) for PE (PE-PRS), high systolic blood pressure (SBP-PRS), coronary artery disease (CAD-PRS) or stroke (stroke-PRS), affects the risk for CVD. MATERIAL AND
methodsThe study was conducted in the FinnGen cohort of 213 942 Finnish women, including 8858 women with PE, 17916 women with any HDP, and 196 026 parous controls. PE women were included in the HDP phenotype. Participants were classified based on their PRSs into three groups: low (<20%), moderate (20-80%) and high (>80%) genetic risk. Women with normotensive pregnancies and moderate PRSs served as controls.
resultsWomen with PE and a high genetic risk for PE, high SBP, CAD, and stroke had a significantly increased risk of CVD compared to women with normotensive pregnancies and a moderate genetic risk. The hazard ratios (HRs) for CVD were 1.87 for PE-PRS, 2.31 for SBP-PRS, 1.94 for CAD-PRS, and 2.07 for stroke-PRS, all p-values 2 × 10
conclusionsIn women with PE or any HDP, a high genetic risk for PE, high SBP, CAD, and stroke further increases the overall risk of CVD. Among women with normotensive pregnancies, a high genetic risk confers only a modest increase in CVD risk. In evaluating long-term CVD risk, clinical risk assessment, including obstetric history, appears to outperform genetic risk evaluation using PRSs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.